99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities

Quarterly Journal of Nuclear Medicine

Volumn 47, Issue 1, 2003, Pages 51-57

  Moustafa, H ^a   Riad, R ^b   Omar, W ^b   Zaher, A ^b   Ebied, E ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Bone neoplasms, radionuclide imaging; Neoplasms, radionuclide imaging; Technetium Tc 99m sestamibi

Indexed keywords

ADRIAMYCINONE; ANTINEOPLASTIC AGENT; IFOSFAMIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ALLOGRAFT; AMPUTATION; ARTICLE; BONE METASTASIS; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DRUG RESPONSE; DRUG UPTAKE; EWING SARCOMA; FEMALE; GIANT CELL TUMOR; HUMAN; INJECTION; INTERMETHOD COMPARISON; LIMB SALVAGE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLASTOMA; OSTEOSARCOMA; PATHOLOGY; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; RADIODIAGNOSIS; RELIABILITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; TUMOR NECROSIS; WHOLE BODY SCINTISCANNING; CHILD; LIMB; PREOPERATIVE CARE; SARCOMA; SCINTISCANNING; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; EXTREMITIES; FEMALE; GIANT CELL TUMORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SARCOMA; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0038693007     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 99mTc-MDP. J Nucl Med 1992;33:319-24.
2. Waxman AD, Ramanna L, Memsic LD, Foster CE, Silberman AW, Gleishman SLT et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
3. Moustafa HM, Omar WM, Ezzat I, Ziada GA, El Ghonaimy E. Thallium single photon emission tomography in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994;15:140-3.
4. Schomacker K, Schicha H. Use of myocardial imaging agents for tumor diagnosis a success story? Eur J Nucl Med 2000;27:1845-65.
5. Menedez LR, Fideler BM, Mira J. Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma. J Bone Joint Surg 1993;75:526-31.
6. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (alkylisonitrile)-technetium (1) in cultured chick myocardial cells. Circulation 1990;82:1926-38.
7. 99mTc-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71.
8. Volm M. Multidrug resistance and its reversal. Anticancer Res 1998;18:2905-17.
9. 99mTc-MIBI in cells with P-glycoprotein mediated and MRP associated multidrug resistance phenotypes. Eur J Biochem 1998;252:140-6.
10. Ling V. Multidrug resistance. Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997;40 Suppl 1:53-8.
11. 99mTc-MIBI scintigraphy in the assessment of MDRI over expression in patients with musculoskeletal sarcoma: Comparison with therapy response. Eur J Nucl Med 2001;28:1341-50.
12. Calarinha P, Almeida O, Fernandes A, Sousinha M, Oliveria P, Salgado I et al. Role of thallium-201 in evaluation of therapeutic response in bone sarcomas [abstract]. Eur J Nucl Med 1998;8:1052.
13. 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy. Eur J Nucl Med 1997;24:511-5.
14. 99mTc-MIBI scintigraphy. J Nucl Med 1997;38:501-6.
15. Chan HSL, Grogan TM, Haddad G, Deboer G, Ling V. P-glycoprotein expression. Critical derminant in response to osteosarcoma chemotherapy. J Natl Cancer Inst 1997;89:1706-15.
16. Lin J, Leung W, Ho SKW, Kumata SM, Metreweli C, Johnson PJ. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995;22:553-6.
17. Kostakoglu L, Panicek DM, Divgic R, Botet J, Healey J, Larson SM et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcoma. Eur J Nucl Med 1995;22:1232-7.
18. 99mTc-MIBI uptake in differentiation between viable and non-viable soft tissue sarcoma. J Egypt Natl Cancer Inst 1999;11:247-52.